Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients
Authors:
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Allergology International
- Vol. 53 (3) , 211-217
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialBMJ, 2003
- Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaThorax, 2003
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Aspirin-induced asthma: Advances in pathogenesis and managementJournal of Allergy and Clinical Immunology, 1999
- A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate AsthmaNew England Journal of Medicine, 1997
- Effect of a thromboxane synthetase inhibitor, ozagrel hydrochloride, on peak expiratory flow in stable asthmatics treated with beclomethasone diproprionateAllergology International, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Effect of a thromboxane A receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthmaJournal of Allergy and Clinical Immunology, 1991
- New concepts in the pathogenesis of bronchial hyperresponsiveness and asthmaJournal of Allergy and Clinical Immunology, 1989
- Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.Thorax, 1986